In vitro studies show that TFPI2 expression inversely correlates with malignancy in cell lines like glioblastoma, lung cancer, prostate cancer, fibrosarcoma, pancreatic ductal adenocarcinoma, gastric cancer, breast cancer, amelanotic melanoma, and thyroid cancer cells [15]. This evidence concerns the gene TFPI2 and fibrosarcoma.